Plunkett Research Online: Aileron Therapeutics Inc

AILERON THERAPEUTICS INC (ALRN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat.....


AILERON THERAPEUTICS INC

Ticker: ALRN
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 995-0900
Fax:
Address: 281 Albany Street
Cambridge, MA 02139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

James WindsorCEO/Director/President
Timothy CunninghamCFO/Chief Accounting Officer
See More
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture